Source: BioPortfolio

Innopharmax: Innopharmax Inc 4172 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250

SummaryInnopharmax Inc InnoPharmax a subsidiary of Synmosa Biopharma Corp is a specialty pharmaceutical company that develops and commercializes products for the treatment of oncology and specialty. The company offers antiinfection agents oncology agents c...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Innopharmax is a Private company. Innopharmax generates $31.4K in revenue per employee Innopharmax has 2 followers on Owler.